Macrobid Related Published Studies
Well-designed clinical trials related to Macrobid (Nitrofurantoin)
One week of nitrofurantoin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: a prospective controlled study. [2011.01]
One-day compared with 7-day nitrofurantoin for asymptomatic bacteriuria in pregnancy: a randomized controlled trial. [2009.02]
Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women. [2007.11.12]
Well-designed clinical trials possibly related to Macrobid (Nitrofurantoin)
Oral antibiotics to prevent postoperative urinary tract infection: a randomized
controlled trial. [2014]
Can a multifaceted educational intervention targeting both nurses and physicians change the prescribing of antibiotics to nursing home residents? A cluster randomized controlled trial. [2011.11]
Different antibiotic regimens for treating asymptomatic bacteriuria in pregnancy. [2010.09.08]
The tools of an evidence-based culture: implementing clinical-practice guidelines in an Israeli HMO. [2009.09]
Women's quality of life is decreased by acute cystitis and antibiotic adverse effects associated with treatment. [2005.07.27]
Isolation of fluoroquinolone-resistant rectal Escherichia coli after treatment of acute uncomplicated cystitis. [2005.07]
Other research related to Macrobid (Nitrofurantoin)
Nitrofurantoin compares favorably to recommended agents as empirical treatment of uncomplicated urinary tract infections in a decision and cost analysis. [2011.06]
[Antimicrobial and clinical efficacy of nitrofurantoin in the treatment of acute lower urinary tract infections in adults]. [2010.10]
Integrated approach to study the dehydration kinetics of nitrofurantoin monohydrate. [2010.09]
One Week of Nitrofurantoin Before Percutaneous Nephrolithotomy Significantly Reduces Upper Tract Infection and Urosepsis: A Prospective Controlled Study. [2010.06.08]
Neurogenic bladder: a complication after endoscopic adhesiolysis with return of bladder function while using nitrofurantoin. [2010.05.01]
Nitrofurantoin pulmonary toxicity: neglected threat. [2010.04]
Acute renal failure from nitrofurantoin-induced acute granulomatous interstitial nephritis. [2010.01]
Probable nitrofurantoin-induced bronchiolitis obliterans with organizing pneumonia. [2009.11.01]
Effect of pregnancy on nitrofurantoin disposition in mice. [2009.11]
Nitrofurantoin-induced systemic inflammatory response syndrome. [2009.10]
Nitrofurantoin-induced acute liver damage in pregnancy. [2009.09]
[Rapid resolution of nitrofurantoin-induced interstitial lung disease] [2009.07]
DRESS syndrome caused by nitrofurantoin. [2009.04]
Differential effects of chrysin on nitrofurantoin pharmacokinetics mediated by intestinal breast cancer resistance protein in rats and mice. [2009]
Nitrofurantoin: the return of an old friend in the wake of growing resistance. [2008.12]
N-(4-[2-(1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl]-phenyl)-9,10-dihydro-5-methoxy-9-oxo-4-acridine carboxamide (GF120918) as a chemical ATP-binding cassette transporter family G member 2 (Abcg2) knockout model to study nitrofurantoin transfer into milk. [2008.12]
Nitrofurantoin-associated bronchiolitis obliterans organizing pneumonia: report of a case. [2008.09]
The ABCG2 C421A polymorphism does not affect oral nitrofurantoin pharmacokinetics in healthy Chinese male subjects. [2008.08]
Chronic eosinophilic pneumonia secondary to long-term use of nitrofurantoin: high-resolution computed tomography findings. [2008.03]
[Nitrofurantoin-induced lung disease: about two cases] [2008.02]
Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline. [2008.01]
Breast cancer resistance protein 1 limits fetal distribution of nitrofurantoin in the pregnant mouse. [2007.12]
Nitrofurantoin neuropathy: a forgotten adverse effect. [2007.08]
Nitrofurantoin-induced lung- and hepatotoxicity. [2007.04]
Severe nitrofurantoin lung disease resolving without the use of steroids. [2007.04]
[Fosfomycin, co-trimoxazole and nitrofurantoin in the treatment of recurrent uncomplicated urinary tract infections in type 2 diabetes mellitus] [2007]
New uses for older antibiotics: nitrofurantoin, amikacin, colistin, polymyxin B, doxycycline, and minocycline revisited. [2006.11]
[Efficacy of nitrofurantoin in the treatment of chronic urinary tract infections in patients with type 2 diabetes mellitus] [2006.11]
[Uncomplicated urinary tract infections, what about fosfomycin and nitrofurantoin in 2006?] [2006.10]
Giant cell interstitial pneumonia associated with nitrofurantoin. [2006.05]
Recurrent acute nitrofurantoin-induced pulmonary toxicity. [2006.05]
Chronic nitrofurantoin-induced lung disease. [2005.10]
Comparison of genomic damage caused by 5-nitrofurantoin in young and adult mice using the in vivo micronucleus assay. [2005.07]
Other possibly related research studies
Diclofenac in the management of E. coli urinary tract infections. [2006.09]
Bioactivation and hepatotoxicity of nitroaromatic drugs. [2006.10]
[Comparative susceptibility evolution in Escherichia coli from urinary tract infections in outpatients and inpatients at Perpignan hospital in 2002 and 2004] [2006.10]
Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections. [2006.11]
Long-term antibiotics for preventing recurrent urinary tract infection in children. [2006.07.19]
[Treatment of uncomplicated lower urinary tract infections] [2005.12]
Antimicrobial susceptibility of pathogens isolated from adult patients with uncomplicated community-acquired urinary tract infections in the Russian Federation: two multicentre studies, UTIAP-1 and UTIAP-2. [2006.08]
Uncomplicated urinary tract infection in women. Current practice and the effect of antibiotic resistance on empiric treatment. [2006.05]
Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study. [2006.06]
[Aetiology and antibiotic sensitivity of the most frequent outpatient infections] [2006.01]
[Summary of the practice guideline 'Urinary-tract infections' (second revision) from the Dutch College of General Practitioners] [2006.04.01]
[The practice guideline 'Urinary-tract infections' (second revision) from the Dutch College of General Practitioners; a response from the perspective of general practice] [2006.04.01]
[Increasing antibiotic resistance in urinary tract infections] [2006.04.06]
Current antibiotic therapy for isolated urinary tract infections in women. [2006.03.27]
Choice of antibiotic for empirical therapy of acute cystitis in a setting of high antimicrobial resistance. [2006.02]
Antibiotic treatment and resistance of unselected uropathogens in the elderly. [2006.03]
Multidrug resistance and distribution of Salmonella serovars in slaughtered pigs. [2006.02]
Antimicrobial resistance in E.coli associated with urinary tract infection in the west of Ireland. [2005.10]
Impact of administrative restrictions on antibiotic use and expenditure in Ontario: time series analysis. [2006.01]
Increased rates of trimethoprim resistance in uncomplicated urinary tract infection: cause for concern? [2005.11.11]
Liquid chromatography-tandem mass spectrometry for the determination of protein-bound residues in shrimp dosed with nitrofurans. [2005.11.16]
Uncomplicated E. coli urinary tract infection in college women: a follow-up study of E. coli sensitivities to commonly prescribed antibiotics. [2005.09]
Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). [2005.11]
Maternal drug use, fertility problems, and infant craniostenosis. [2005.11]
Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey. [2005.11]
Antibiotics and the risk of breast cancer. [2005.09]
Frequency and treatment of urinary tract infection in children subjected to urine culture, in Sana'a, Yemen. [2005.04]
Asymptomatic bacteriuria in men with orthotopic ileal neobladders: possible relationship to nocturnal enuresis. [2005.08]
Inappropriate drug prescribing in older adults: the updated 2002 Beers criteria--a population-based cohort study. [2005.08]
Uncomplicated urinary tract infections. Bacterial findings and efficacy of empirical antibacterial treatment. [2005.06]
The occurrence of nitrofuran metabolites in the tissues of chickens exposed to very low dietary concentrations of the nitrofurans. [2005.06]
Natural antimicrobial susceptibility patterns of Kluyvera ascorbata and Kluyvera cryocrescens strains and review of the clinical efficacy of antimicrobial agents used for the treatment of Kluyvera infections. [2005.04]
Antimicrobial resistance in urinary bacterial isolates from pregnant women in rural Tanzania: implications for public health. [2005]
Human immunodeficiency virus, pregnancy, and Stevens-Johnson syndrome. [2005.05]
[Changes in the antimicrobial susceptibility of Escherichia coli isolates from nosocomial versus community-acquired urinary tract infections] [2005.04]
[Evaluation of levofloxacin susceptibility against strains isolated from lower urinary tract infections in the community.] [2005.03]
[Etiology and antimicrobial susceptibility among uropathogens causing community-acquired lower urinary tract infections: a nationwide surveillance study] [2005.01]
Furazolidone-induced pulmonary hypersensitivity. [2005.02]
Management of urinary tract infections in female general practice patients. [2005.02]
Management of urinary tract infections: historical perspective and current strategies: Part 2--Modern management. [2005.01]
Physician speciality and adherence to guidelines for the treatment of unsubstantiated uncomplicated urinary tract infection among women. [2005.05]
[Using antibiotics in urinary tract infection in a first level of attention health care unit in Bogota, Colombia] [2006.05]
Pharmaceutical agents and pregnancy in urology practice. [2007.02]
A study of sensitivity and resistance of pathogenic micro organisms causing UTI in Kathmandu valley. [2005.04]
Determination of nitrofuran residues in milk of dairy cows using liquid chromatography-tandem mass spectrometry. [2007.03.21]
[Recurrent urinary tract infection in women. Long-term antibiotic prophylaxis] [2006.04]
[Crystalline retinopathy] [2007]
Acute pyelonephritis in pregnancy: a retrospective study. [2007.08]
Urinary tract infections in Brescia, Italy: etiology of uropathogens and antimicrobial resistance of common uropathogens. [2007.06]
The significance of compliance for the success of antimicrobial prophylaxis in recurrent lower urinary tract infections: the Greek experience. [2007.07]
Ciprofloxacin and furagin in acute cystitis: comparison of early immune and microbiological results. [2007.11.28]
Impact of a fluoroquinolone restriction policy in an elderly population. [2007.10]
In vitro susceptibility of community-acquired urinary tract pathogens to commonly used antimicrobial agents in Spain: a comparative multicenter study (2002-2004). [2007.06]
Interpretation of the 13C-urea breath test in the choice of second- and third-line eradication of Helicobacter pylori infection. [2008]
[Acute cystitis in women with type 2 diabetes. Three antimicrobial schemes] [2007.09]
Assay for integrons and pattern of antibiotic resistance in clinical Escherichia coli strains by PCR-RFLP in Southern Iran. [2008.01]
Ten years surveillance of antimicrobial susceptibility of community-acquired Escherichia coli and other uropathogens in northern Israel (1995-2005). [2007.11]
Ciprofloxacin and furagin in acute cystitis: comparison of early immune and microbiological results. [2008.02]
Significant increase in the isolation of glycopeptide-resistant enterococci from patients hospitalized in the transplant surgery ward in 2004-2005. [2007.11]
|
